-transparent.png){kind=logo}
A glucose-controlled insulin infusion system (Biostator) was used to determine patient insulin requirement for clinical evaluation of a portable pump system (technical development by Siemens AG). Results from 6 insulin-dependent diabetics with respect to quality of control, carbohydrate/insulin ratio, and insulin requirement are shown. Preprogrammed insulin infusion with the portable system was carried out for up to 117 days.
Related Publications
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
February 1980,
The American journal of medicine,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
July 1980,
Texas medicine,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
January 1980,
Medical progress through technology,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
March 1983,
Medicina clinica,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
March 1982,
Journal of the Medical Association of Georgia,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
November 1979,
Diabetes,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
January 1981,
Diabetes care,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
January 1979,
Hormone and metabolic research. Supplement series,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
January 1980,
Diabetes care,
K Irsigler, and
H Kritz, and
L Kaspar, and
J Brändle, and
W Koller, and
M Franetzki
March 1982,
Deutsche medizinische Wochenschrift (1946),
